Effect of acetylcholinesterase inhibitors on the binding of nicotinic α4β2 receptor PET radiotracer, 18F-nifene: A measure of acetylcholine competition

Synapse

Volumn 61, Issue 1, 2007, Pages 29-36

  Easwaramoorthy, Balasubramaniam ^a   Pichika, Rama ^a   Collins, Daphne ^a   Potkin, Steven G ^a   Leslie, Frances M ^b   Mukherjee, Jogeshwar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

4 2 nicotine receptors; 18F nifene; Acetylcholine; Galanthamine; PET; Physostigmine

Indexed keywords

ACETYLCHOLINE; CYTISINE; GALANTAMINE; NICOTINE; NICOTINIC ALPHA4BETA2 RECEPTOR; NICOTINIC RECEPTOR; NIFENE F 18; PHYSOSTIGMINE; TRACER; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING ASSAY; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; FEASIBILITY STUDY; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ACETYLCHOLINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHOLINESTERASE INHIBITORS; FLUORINE RADIOISOTOPES; GALANTAMINE; MALE; PHYSOSTIGMINE; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 33845543915     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20338     Document Type: Article

References (27)

1. Buxton DA, Brimblecombe RW, French MC, Redfern PH. 1976. Brain acetylcholine concentration and acetylcholinesterase activity in selectively bred strains of rats. Psychopharmacology 47:97-99.
2. Chang Q, Savage LM, Gold PE, 2006, Microdialysis measures of functional increase in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate. J Neurochem 97:697-706.
3. Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. 2005. Synthesis and evaluation of nicotine α4β2 receptor ligand, 5-(3′- fluoropropyl)-3-(2-(S)-pyrrolidinyl)methoxy)pyridine in rodents and imaging by PET in non-human primate. J Nucl Med 46:130-140.
4. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG. 2003. Graphical analysis of 2-[F-18]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48:25-34.
5. Cheng YC, Prusoff WH. 1973. Relationship between the inhibition constant and the concentration of inhibitor which cause 50 percent of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. Dolle F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C. 1999. Synthesis and nicotinic acetylcholine receptors in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy] pyridine: A new positron emission tomography ligand for nicotinic receptors. J Med Chem 42:2251-2259.
7. 18F]fluoroepibatidine. J Neurochem 74:1514-1521.
8. Fujita M, Al-Tikriti MS, Tamagnan G, Zoghbi SS, Bozkurt A, Baldwin RM, Innis RB. 2003. Influence of acetylcholine levels on the binding of a SPECT nicotmic acetylcholine receptor ligand, 1231-5-IA85380. Synapse 48:116-122.
9. Giacobini E. 2000. Cholinesterase inhibitors stabilize Alzheimer's disease. Neurochem Res 25:1185-1190.
10. Guo N, Hwang DR, Lo ES, Huang YY, Laruelle M, Abi-Dargham A. 2003. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: Implications for imaging studies in schizophrenia. Neuropsychopharmacology 28:1703-1711.
11. 3H-cytisine. Neuroscience 62:929-944.
12. Himmelheber AM, Fadel J, Sarter M, Bruno JP. 1998. Effects of local cholinesterase inhibition on acetylcholine release assessed simultaneously in prefrontal and frontoparietal cortex. Neuroscience 86:949-957.
13. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, vanden-Bussche H. 2005. Cholinesterasse inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ 331:321-327.
14. Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. 2000. Limited donepzil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer's cerebral cortex. Ann Neurol 48:391-396.
15. Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. 2006. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Ann Neurol 59:13-20.
16. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20:423-451.
17. 11C-NMPYB) to endogenous acetylcholine: PET imaging vs. tissue sampling methods. Nucl Med Biol 31:393-397.
18. Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper M, Seiden LS. 1997. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, [F-18]fallypride in non-human primates using positron emission tomography. Synapse 27:1-13.
19. Mukherjee J, Christian BT, Shi B, Narayanan TK, Mantil J. 2001. Evaluation of dopamine D-2 receptor occupancy in vivo by clozapine, risperidone and haloperidol in rodents and non-human primates using 18F-fallypride. Neuropsychopharmacology 25:476-488.
20. 3H-Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9-12.
21. Pappata S, Tavitian B, Traykov L, Jobert A, Dalger A, Mangin JF, Crouzel C, DiGiamberardino L. 1996. In vivo imaging of human cerebral acetylcholinesterase. J Neurochem 67:876-879.
22. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ. 2002. Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtype in rat tissues by autoradiography. J Neurochem 82:468-481.
23. 18F-Nifene) in rodents and imaging by PET in non-human primate. Nucl Med Biol 33:295-304.
24. Smulders CJGM, Zwart R, Bermudez I, vanKleef RGDM, Groot-Kormelink PJ, Vijverberg HPM. 2005. Cholinergic drugs potentiate human nicotinic α4β2 acetylcholine receptors by a competitive mechanism. Eur J Pharm 509:97-108.
25. Udo de Haes JI, Harada N, Eisinga PH, Maguire RP, Tsukada H. 2006. Effect of fenfluramine-induced increases in serotonin release on [18]F-MPPF: A continuous infusion PET study in conscious monkeys. Synapse 59:18-26.
26. 18F-Fluoro-A-85380: A PET study in monkeys. Synapse 56:217-221.
27. White BJ, Legako JA, Harmon HJ. 2003. Extended lifetime of reagent less detector for multiple inhibitors of acetylcholinesterase. Biosens Bioelectron 18:729-734.